This page provides you with the latest information, publications, and news articles on the evolving novel coronavirus outbreak from trusted sources. (last updated July 5, 2020)

ISID stands behind Wellcome's statement on sharing research data and findings relevant to the novel coronavirus (nCoV) outbreak

COVID-19 Chapter in ISID's Guide to Infection Control in the Healthcare Setting

The city of Wuhan in China has been the focus of global attention since December 2019 due to an outbreak of pneumonia linked to a market with live animals for sale. Chinese scientists have since isolated a novel coronavirus (nCoV), but many questions about this nCoV remain.

Follow the COVID-19 Outbreak with ProMED

ProMED, our Program for Monitoring Emerging Diseases, first reported on what has now been identified as COVID-19 (SARS-CoV-2)  out of Wuhan, China on December 30, 2019, when it was still an undiagnosed pneumonia. ProMED continues to keep you up-to-date in real time. Be sure to sign up for ProMED alerts here.

The Latest COVID-19 Case Counts



The IJID and COVID-19

The International Journal on Infectious Diseases (IJID) editors will rapidly evaluate submitted manuscripts concerning the evolving COVID-19/SARS-CoV-2 outbreak. Journal staff will expedite copyediting and publishing steps for accepted manuscripts to make data available as quickly as possible. The IJID is an open-access journal, and all articles are freely available. Authors are encouraged to openly share original data with others. Submit your manuscript here.

COVID-19 Clinical Resources Repository: Clinical Protocols and Guidelines

With the support of different scientific societies and experts of different medical specialties (e.g., internal medicine, critical care, pneumology, pediatrics), the Colombian Association of Infectious Diseases (ACIN) developed the “Colombian consensus recommendations for diagnosis, management and treatment of the infection by SARS-COV-2/COVID-19 in health care facilities - Recommendations from expert´s group based and informed on evidence”.
Thank you to Dr. Alfonso Rodriguez-Morales for submitting the link to this resource

A Syndromic approach to SARS-CoV-2 – What to do if no COVID-19 testing is available
Thank you to Dr. Olivia Farrant for submitting this protocol. Thank you to Dr Dan Youkee (editing), Dr Mary Bunn (palliative care guidance for COVID-19 in a low-income setting), Dr Hannah Dabrowski (HIV inpatient checklist) and Dr Arthur Clegg (Malaria inpatient management flowchart)

Mayo Clinic, Rochester, MN (USA) – COVID-19 Navigator, Clinical guidance reviewed and updated daily
Thank you to Dr. Nipunie Rajapaske for submitting the link to this resource.

Hospital Italiano de Mendoza, Mendoza, Argentina - Personal de salud y pandemia por SARS-CoV-2 - Prevención y manejo de exposición
Thank you to Dra. Andrea Vila for submitting this resource.

SHRI (Samishta Hospital & Research Institute), Guntur, Andhra Pradesh, India - SHRI Hospital working policy in the current COVID-19 pandemic
Thank you to Dr. Kognati Kalyan for submitting this resource.

Anesthesia Department, Morriston Hospital, Wales, UK - COVID-19 staff wellbeing and mental health SOP
Thank you to Dr. Linn Jarte for submitting this resource.

Massachusetts General Hospital Clinical COVID-19 Resources
Clinical protocols from MGH – available in English and Spanish

University of Washington Clinical COVID-19 Resources 
Clinical protocols developed by University of Washington Medical

University of Nebraska Clinical COVID-19 Resources

University of Washington IDEA COVID-19 Treatment Resource
Treatments that are being considered for COVID-19 - Prescribing Information, Clinical Studies, and Slide Decks

American Society of Health-System Pharmacists chart review of evidence on pharmaceutical treatments for COVID-19. 

Ministry of Health Malaysia - COVID-19 Guidelines
Thank you to Dr. Ahmad Nizal Mohd Ghazali for submitting the link to this resource.

This repository is provided for informational purposes only and is intended to supplement, but not overrule, the judgment of a qualified medical professional. Knowledge related to the ongoing COVID-19 pandemic is in rapid flux and ISID cannot guarantee that resources are kept up-to-date. All information is meant for use by clinicians, and does not constitute provision of medical advice.

The Lancet has created a Coronavirus Resource Centre. This resource brings together new 2019 novel coronavirus (2019-nCoV) content from across The Lancet journals as it is published. All content listed on this page is free to access.

New England Journal of Medicine: A collection of articles and other resources on the 2019 Novel Coronavirus outbreak, including clinical reports, management guidelines, and commentary.

Imperial College London - MRC Centre for Global Infectious Disease Analysis: Reports on Transmissibility and Estimation on the potential total number of novel Coronavirus (2019-nCoV) cases in China

Journal of Travel Medicine - Top 20 passenger destination cities and direct + total flight volume from Wuhan, China, where novel coronavirus was confirmed.

Corona Free Collection at The Royal Society of Tropical Medicine and Hygiene

JAMA Network Coronavirus Resource Center

ResearchGate's Combating COVID-19

How ProMED Crowdsourced the Arrival of COVID-19 and SARS WIRED

WIRED's Maryn McKenna interviews Dr. Marjorie Pollack, ProMED Deputy Editor, on how ProMED crowdsourced the arrival of COVID-19.

The Doctor Whose Gut Instinct Beat AI in Spotting the Coronavirus OLIVER WYMAN FORUM

Identifying an emerging disease outbreak against the background noise of ongoing infections is a difficult task. ProMED's Deputy Editor, Marjorie Pollack, has done it - twice. Her role in alerting the international community to COVID-19 is captured in this recent interview.

Lessons From Coronavirus for Future Climate Change Public Health Crises FORBES

Lessons for how to manage the next outbreak include, "creating a best practices database – ProMED model."

When will a coronavirus vaccine be ready? Independent Online/The Guardian

There is currently a spattering of hyped articles that a vaccine trial is about to begin in humans in Seattle Washington, USA, tomorrow (15 Mar 2020]. For those who don't work in vaccine development, this article is an excellent "vaccinology 101" article, explaining the challenges and stages of testing as part of the vaccine development process. It also should help understand why a realistic timetable is 12-18 months at the best. - Mod.MPP